{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:14:53Z","timestamp":1789013693739,"version":"build-2803163510"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T00:00:00Z","timestamp":1299196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T00:00:00Z","timestamp":1299196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/leu.2011.37","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T09:40:02Z","timestamp":1299231602000},"page":"953-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"25","author":[{"given":"G","family":"Escherich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L C","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,4]]},"reference":[{"key":"BFleu201137_CR1","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","volume":"102","author":"DO Harms","year":"2003","unstructured":"Harms DO, Gobel U, Spaar HJ, Graubner UB, Jorch N, Gutjahr P et al. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 2003; 102: 2736\u20132740.","journal-title":"Blood"},{"key":"BFleu201137_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","volume":"368","author":"A Vora","year":"2006","unstructured":"Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006; 368: 1339\u20131348.","journal-title":"Lancet"},{"key":"BFleu201137_CR3","first-page":"156a","volume":"100","author":"LC Stork","year":"2002","unstructured":"Stork LC, Sather H, Hutchinson HJ, Broxson EH, Matloub Y, Yanofsky R et al. Comparison of mercaptopurine (MP) with thioguanine (TG) and IT methotrexate (ITM) with IT \u2018Triples\u2019 (ITT) in children with SR-ALL: results of CCG-1952. Blood 2002; 100: 156a, A585.","journal-title":"Blood"},{"key":"BFleu201137_CR4","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","volume":"115","author":"LC Stork","year":"2010","unstructured":"Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H et al. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood 2010; 115: 2740\u20132748.","journal-title":"Blood"},{"key":"BFleu201137_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2141.2009.07624.x","volume":"145","author":"Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)","year":"2009","unstructured":"Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG). Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. Br J Haematol 2009; 145: 376\u2013388.","journal-title":"Br J Haematol"},{"key":"BFleu201137_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557\u2013560.","journal-title":"BMJ"},{"key":"BFleu201137_CR7","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","volume":"7","author":"L Lennard","year":"1989","unstructured":"Lennard L, Lilleyman JS . Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol 1989; 7: 1816\u20131823.","journal-title":"J Clin Oncol"},{"key":"BFleu201137_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/bjc.1984.111","volume":"49","author":"JS Lilleyman","year":"1984","unstructured":"Lilleyman JS, Lennard L, Rees CA, Morgan G, Maddocks JL . Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. Br J Cancer 1984; 49: 703\u2013707.","journal-title":"Br J Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201137","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:21:33Z","timestamp":1648736493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,4]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFleu201137"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.37","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,4]]},"assertion":[{"value":"1 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}